Medicine News and Research

RSS

Embrella Embolic Deflector device highlighted during JIM 2010 meeting in Rome

Embrella Cardiovascular™, Inc., a privately held company announced that the Embrella Embolic Deflector™ device was highlighted during a live case transmission last week at the Joint Interventional Meeting (JIM) in Rome, Italy.

19 Feb 2010

10th Annual Conference for Young Women Affected by Breast Cancer

Young women diagnosed with breast cancer are uniquely impacted by issues often not faced by older women. Breast cancer is often detected at later stages, increasing diagnoses of more advanced cancers. The impact of cancer treatment on fertility, body image, financial challenges, and slightly higher mortality rates are significant concerns for this population.

19 Feb 2010

New Jersey Superior Court links Roche's Accutane to IBD

In another major courtroom verdict linking powerful acne medication Accutane with long-term inflammatory bowel disease (IBD), a nine-person New Jersey jury has found that pharmaceutical maker Hoffman-La Roche Inc. failed to provide an adequate warning of the possible condition to Andrew McCarrell's prescribing physician, which then led to his development of chronic IBD. Mr. McCarrell, who was 23 at the time he took Accutane, developed a severe case of IBD and thereafter had his colon removed. The jury awarded compensatory damages of $25.16 million to Andy, now in his thirties.

19 Feb 2010

PsychoGenics announces alliance with experimental neuropharmacology expert for specialized microdialysis services

PsychoGenics Inc. today announced the establishment of an exclusive alliance with Dr. Jan Kehr, an internationally recognized expert in experimental neuropharmacology, to provide specialized microdialysis services to complement PsychoGenics’ in vivo testing capabilities.

19 Feb 2010

SRI International establishes new Neurodegenerative Diseases Research Program

SRI International, an independent nonprofit research and development institute, announced today that a new Neurodegenerative Diseases Research Program has been established within its Center for Health Sciences. This new SRI group of neuroscientists and researchers working at the cutting edge of science brings $6.2 million of funding from the National Institutes of Health (NIH), including the National Institute of Neurological Disorders and Stroke (NINDS), the National Institute of Environmental Health Sciences (NIEHS), and National Institute of General Medical Sciences (NIGMS).

19 Feb 2010

NIA supports FDA initiative to reduce radiation overexposure from medical imaging

National Imaging Associates (NIA), a Magellan Health Services company, today applauded the U.S. Food and Drug Administration (FDA) for its leadership and progress in addressing the issue of radiation overexposure through its Initiative to Reduce Unnecessary Radiation Exposure from Medical Imaging.

19 Feb 2010

Study shows how genes and environmental factors influence common human diseases

A UCLA study reveals how human genes interact with their environment to boost disease risk. Published in the Feb. 18 online edition of the American Journal of Human Genetics, the findings shed light on why the search for specific gene variants linked to human diseases can only partly explain common disorders.

19 Feb 2010

Researchers use Life Technologies’ next-generation sequencing instruments for cancer research

Life Technologies Corporation today announced the publication of two key scientific papers that highlight the utility of next-generation sequencing instruments in better understanding disease and the genetic differences that cause diversity within and between human populations. The Applied Biosystems SOLiD™ System was used in both of these research studies.

19 Feb 2010

Patient registry formed to track clinical course of hypoactive sexual desire disorder

New findings from a European study show that women with low sexual desire and associated distress experience personal and emotional distress related to the sexual issue.

19 Feb 2010

VIRxSYS announces results from prophylactic HIV vaccine study at 2010 CROI conference

VIRxSYS Corporation, a privately held company developing vaccines and RNA therapies for serious human diseases such as HIV and cardiovascular diseases, announced results from its prophylactic HIV vaccine (VRX1023) study in Rhesus Macaque monkeys during a presentation today at the 2010 Annual Conference on Retroviruses and Opportunistic Infections (CROI) in San Francisco, CA.

19 Feb 2010

UBC researcher finds improved uptake of highly active antiretroviral therapy

A comprehensive population-based study, conducted by the BC Centre for Excellence in HIV/AIDS (BC-CfE) and presented at the 17th Conference on Retroviruses and Opportunistic Infections in San Francisco, shows that expanded highly active antiretroviral therapy (HAART) coverage was associated with a 50% decrease in new yearly HIV infections among injection drug users.

19 Feb 2010

Researchers develop technology to preserve vaccines in tropical temperatures

A team of British researchers have developed a simple, low-cost method to preserve vaccines in tropical climates, which they say could help to revolutionalize vaccination campaigns in developing countries, Reuters reports.

19 Feb 2010

UCSF team: NIH ethics guidelines for embryonic stem cell research need to be modified

A UCSF team, led by bioethicist Bernard Lo, MD, recommends that the National Institutes of Health ethics guidelines for embryonic stem cell research be modified to better protect the rights of individuals donating egg or sperm to patients undergoing in vitro fertilization.

19 Feb 2010

Lucile Packard Children’s Hospital gearing up for National Eating Disorders Awareness Week

Lucile Packard Children’s Hospital at Stanford is gearing up for National Eating Disorders Awareness Week, Feb. 21 – 27. The hospital's Comprehensive Eating Disorders Program is reaching out to Bay Area families to enhance knowledge of anorexia nervosa, bulimia nervosa and related diagnoses.

19 Feb 2010

Two UCSF scientists selected for Potamkin Prize for their achievements in research on dementias

Two UCSF scientists have been selected for the American Academy of Neurology's prestigious Potamkin Prize, for their "outstanding achievements" in research on dementias.

19 Feb 2010

Blood transfusions based on single low hematocrit measurement questioned

A comparison study of nearly 1,900 patients published in Perfusion, a peer-reviewed academic journal, questions the long-standing practice of basing blood transfusion decisions on a single low hematocrit measurement result. In the study, titled Is it the Patient or the Physician who Cannot Tolerate Anemia?, researchers showed that a single measure of hematocrit is not a reliable indicator of transfusion need and that lower-than-normal hemoglobin levels have no adverse impact on patients.

19 Feb 2010

Study: Elderly people with untreated visual disorders more likely to develop Alzheimer's disease

Elderly people with visual disorders that are left untreated are significantly more likely to develop Alzheimer's disease -- the most common form of dementia, according to a University of Michigan Health System study.

19 Feb 2010

Mechanosensitive ion channels play a key role in pain sensation

Humans and animals are able to perceive even the slightest vibration and touch of the skin. Mechanosensitive ion channels play a crucial role in the mediation of these sensations. Ion channels are pores in the cell membrane which are highly responsive to external signals.

19 Feb 2010

Training birth attendants in essential newborn-care techniques reduce stillbirths by 30%: Study

New findings in a study led by the director of the University of Alabama at Birmingham (UAB) Division of Neonatology show that that training birth attendants in essential newborn-care techniques reduced stillbirths by more than 30 percent - and potentially could save as many as 1 million lives worldwide each year.

19 Feb 2010

Johns Hopkins Kimmel Cancer Center scientists develop genome-based blood tests for cancer

Scientists at the Johns Hopkins Kimmel Cancer Center have used data from the whole genome sequencing of cancer patients to develop individualized blood tests they believe can help physicians tailor patients' treatments. The genome-based blood tests, believed to be the first of their kind, may be used to monitor tumor levels after therapy and determine cancer recurrence.

19 Feb 2010

Medicine News and Research

Embrella Embolic Deflector device highlighted during JIM 2010 meeting in Rome

10th Annual Conference for Young Women Affected by Breast Cancer

New Jersey Superior Court links Roche's Accutane to IBD

PsychoGenics announces alliance with experimental neuropharmacology expert for specialized microdialysis services

SRI International establishes new Neurodegenerative Diseases Research Program

NIA supports FDA initiative to reduce radiation overexposure from medical imaging

Study shows how genes and environmental factors influence common human diseases

Researchers use Life Technologies’ next-generation sequencing instruments for cancer research

Patient registry formed to track clinical course of hypoactive sexual desire disorder

VIRxSYS announces results from prophylactic HIV vaccine study at 2010 CROI conference

UBC researcher finds improved uptake of highly active antiretroviral therapy

Researchers develop technology to preserve vaccines in tropical temperatures

UCSF team: NIH ethics guidelines for embryonic stem cell research need to be modified

Lucile Packard Children’s Hospital gearing up for National Eating Disorders Awareness Week

Two UCSF scientists selected for Potamkin Prize for their achievements in research on dementias

Blood transfusions based on single low hematocrit measurement questioned

Study: Elderly people with untreated visual disorders more likely to develop Alzheimer's disease

Mechanosensitive ion channels play a key role in pain sensation

Training birth attendants in essential newborn-care techniques reduce stillbirths by 30%: Study

Johns Hopkins Kimmel Cancer Center scientists develop genome-based blood tests for cancer

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News